Recent advances and findings of angiotensin type 2 receptor: A review

Chinese Medical Journal

Volumn 123, Issue 23, 2010, Pages 3462-3466

  Zuo, Yu Mei ^a   Wang, Yuan ^a   Liu, Jian Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin type 2 receptor; Cardiovascular system; Overexpression; Polymorphism; Signal transduction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR AGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC PANCREATITIS; DRUG EFFICACY; DRUG SAFETY; FEEDBACK SYSTEM; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HEMODYNAMICS; HUMAN; HYPERTENSION; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIGANDS; POLYMORPHISM, GENETIC; RECEPTOR CROSS-TALK; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 78649832452     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.23.016     Document Type: Article

References (44)

1. Basso N, Terragno NA. History about the discovery of the renin-angiotensin system. Hypertension 2001; 38: 1246-1249.
2. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology, XXTTT. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415-472.
3. Schulman IH, Zhou M, Raij L. Cross-talk between angiotensin II receptor type 1 and 2: potential role in vascular remodeling in human. Hypertension 2007; 49: 270-271.
4. Widdop RE, Vinh A, Henrion D, Jones ES. Vascular angiotensin AT2 receptors in hypertension and aging. Clin Exp Pharmacol Physiol 2008; 35: 386-390.
5. Shanmugam S, Corvol P, Gasc JM. Angiotensin II type II receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension 1996; 28: 91-97.
6. Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE. AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 2008; 120: 292-316.
7. Rocken C, Rohl F, Diebler RE, Lendeckel U, Pross M, Carl-McGrath S, et al. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1206-1212.
8. Martin MM, Elton TS. The sequence and genetic organization of the human type 2 angiotensin II receptor. Biochem Biophys Res Commun 1995; 209: 554-562.
9. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 1999; 3: 1-10.
10. Zivković M, Djurić T, Stancić O, Alavantić D, Stanković A. X-linked angiotensin II type 2 receptor gene polymorphism -1332A/G in male patients with essential hypertension. Clin Chim Acta 2007; 386: 110-113.
11. Sullivan JA, Rupnow HL, Cale JM, Magness RR, Bird IM. Pregnancy and ovarian steroid regulation of angiotensin II type 1 and type 2 receptor expression in ovine uterine artery endothelium and vascular smooth muscle. Endothelium 2005; 12: 41-56
12. Akbar SA, Khawaja NP, Brown PR, Tayyeb R, Bamfo J, Nicolaides KH. Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations. Acta Obstet Gynecol Scand 2009; 23:1-6.
13. Kotani K, Fujiwara S, Tsuzaki K, Sano Y, Matsuoka Y, Hamada T, et al. An association between angiotensin II type 2 receptor gene A/C3123 polymorphism and glycemic control marker in a general Japanese population. Mol Biol Rep 2009; 36: 917-920.
14. Orlowska-Baranowska E, Placha G, Baranowski R, Michalek P, Gora J, Gaciong Z, et al. Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis? J Heart Valve Dis 2007; 16: 495-503.
15. Siomou E, Bouba I, Kollios KD, Papadopoulou F, Syrrou M, Georgiou I, et al. Angiotensin II type 2 receptor gene polymorphism in Caucasian children with a wide spectrum of congenital anomalies of the kidney and urinary tract. Pediatr Res 2007; 62: 83-87.
16. Zhang M, Ma H, Wang BS, Zhao YZ. Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension. Heart Vessels 2006; 21: 95-101.
17. Abadir PM, Periasamy A, Carey RM, Siragy HM. Angiotensin II type 2 receptor-bradykinin B2 receptor functional hetero- dimerization. Hypertension 2006; 48: 316-322.
18. Zhang Q, He F, Kuruba R, Gao X, Wilson A, Li J, et al. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc Res 2008; 77: 560-569.
19. Su J, Palen DI, Boulares H, Matrougui K. Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to ANG I. Mol Cell Biochem 2008; 311: 1-7.
20. Walters PE, Gaspari TA, Widdop RE. Angiotensin (1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 2005; 45: 960-966.
21. Schulman IH, Zhou M, Raij L. Cross-talk between angiotensin II receptor types 1 and 2: potential role in vascular remodeling in humans. Hypertension 2007; 49: 270-271.
22. Mitsuishi M, Miyashita K, Muraki A, Itoh H. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control. Diabetes 2009; 58: 710-717.
23. Okada H, Inoue T, Kikuta T, Watanabe Y, Kanno Y, Ban S, et al. A possible anti-inflammatory role of angitensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade. Am J Pathol 2006; 169: 1577-1589.
24. Yayama K, Okamoto H. Angiotensin type 2 receptor- dependent vasodilation. Yakugaku Zasshi 2007; 127: 1357-1367.
25. Ruiz-Ortega M, Rupérez M, Esteban V, Rodríguez-Vita J, Sánchez-López E, Carvajal G, et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21: 16-20.
26. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001; 276: 39721-39726.
27. Heagerty AM. Influence of changes of blood pressure on vascular angiotensin II receptor subtype expression. Circulation 2005; 111: 956-957.
28. Takeuchi Y, Yamauchi K, Nakamura J, Shigematsu S, Hashizume K. Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation. J Endocrinol 2006; 191: 361-367.
29. Sullivan JA, Rupnow HL, Cale JM, Magness RR, Bird IM. Pregnancy and ovarian steroid regulation of angiotensin II type 1 and type 2 receptor expression in ovine uterine endothelium and vascular smooth muscle. Endothelium 2005; 12: 41-56.
30. Horiuchi M, Mogi M, Iwai M. Signaling crosstalk angiotensin II receptor subtypes and insulin. Endocr J 2006; 53: 1-5.
31. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1991; 30: 1238-1246.
32. Barker TA, Massett MP, Korshunov VA, Mohan AM, Kennedy AJ, Berk BC. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension 2006; 48: 942-949.
33. Harada S, Nakata T, Oguni A, Kido H, Hatta T, Fukuyama R, et al. Contrasting effects of angiotensin type 1 and 2 receptors on nitric oxide release under pressure. Hypertens Res 2002; 25: 779-786.
34. Lee JH, Xia S, Ragolia L. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comp Physiol 2008; 295: R144-R154.
35. Mii A, Shimizu A, Masuda Y, Ishizaki M, Kawachi H, Iino Y, et al. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression. Lab Invest 2009; 89: 164-177.
36. Li H, Gao Y, Grobe JL, Raizada M, Katovich MJ, Sumners C. Potentiation of the antihypertensive action of losartan by peripheral overexpression of the Ang II type 2 receptor. Am J Physiol Heart Circ Physiol 2007; 292: H727-H735.
37. Gao L, Wang WZ, Wang Z, Li H, Sumners C, Zucker IH. Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 2008; 51: 521-527.
38. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P, Dzau VJ, Pratt RE. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005; 112: 3328-3336.
39. Dandapat A, Hu CP, Chen J, Liu Y, Khan JA, Remeo F, et al. Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochm Biophys Res Commun 2008; 366: 871-877.
40. Hu C, Dandapat A, Chen J, Liu Y, Hermonat PL, Carey RM, et al. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis 2008; 199: 288-294.
41. Guilluy C, Rolli-Derkinderen M, Loufrani L, Bourgé A, Henrion D, Sabourin L, et al. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation. Circ Res 2008; 102: 1265-1274.
42. Yamada T, Kuno A, Ogawa K, Tang M, Masuda K, Nakamura S, et al. Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats. J Pharmacol Exp Ther 2005; 313: 36-45.
43. Messerli FH. The sudden demise of dual rennin-angiotensin system blockade or the soft science of the surrogate end point. J Am College Cardiol 2009; 53: 468-470.
44. Topol EJ. Past the wall in cardiovascular R&D. Nat Rev Drug Discov 2009; 8: 259.